A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression

Clinical trial NCT03852160 · WITHDRAWN

Trial details

NCT number: NCT03852160
Sponsor: Janssen-Cilag International NV
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Treatment-Resistant

Start date: 2019-12-01
Primary completion: 2021-07-25
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.